ARN News

Analysis of the American Rheumatology Network-Trio Health (ARN-Trio) registry finds that AbbVie’s Rinvoq use is increasing rapidly as a proportion of JAK inhibitor use. Rheumatologists

American Rheumatology Network (ARN) and Trio Health (Trio) have launched the first rheumatology registry that combines pharmacy dispensing data with electronic medical records (EMR) to

The American Rheumatology Network (ARN) has been so successful with cost management, particularly via the use of biosimilars, that it believes its model is worthy

by Colin Edgerton We are seeing COVID-19 cases peak in many areas of the US, prompting thoughts about what comes next for rheumatology practices. Many

As of 12:30pm ET on March 17, 2020 CMS has sent out an official notification stating that effective for services starting March 6, 2020 (retroactive),

The American Rheumatology Network (ARN) continues to monitor federal, state and local health advisories regarding the coronavirus (COVID-19) and will update this resource accordingly.  Please

Updated March 17, 2020 3:00pm American Rheumatology Network (ARN) members are concerned about safe access to care during the COVID-19 pandemic. The Centers for Disease

Originally published in The Rheumatologist The Centers for Medicare & Medicaid Services (CMS) Physician Fee Schedule final rule for 2020 includes a big win for

Charleston, SC, Feb. 18, 2020 – American Rheumatology Network (ARN) announces their partnership with Framework Management Information, Inc. (Framework) to develop AXCESS1, a new prescription

Originally published in Biosimilar Development In the first installment of this four-part series, the members of the Biosimilar Development Editorial Board and friends discussed how

Originally published in Biosimilar Development As we close out another year of global biosimilar successes and twists and turns, it’s always important to take stock

Originally published in The Rheumatologist For patients responsible for out-of-pocket costs associated with high-deductible health insurance plans, the financial burden associated with rheumatologic care can

WASHINGTON, Nov. 12, 2019 /PRNewswire/ — Trio Health, a leading provider of real-world evidence, announced results from a study recently presented at the Annual Meeting of the

By Karen Ferguson, CEO of Discus Analytics, LLC. Discus Analytics and American Rheumatology Network (ARN) have announced a new partnership, designed to provide much-needed tools

Originally published on PRNewsWire.com WASHINGTON, Oct. 8, 2019 /PRNewswire/ — Trio Health, a leading provider of real-time data on real-world patients, today announced the creation of the